Cargando…
The Role of Cell-Free DNA in Cancer Treatment Decision Making
SIMPLE SUMMARY: The aim of this review is to evaluate the present status of the use of cell-free DNA and its fraction of circulating tumor DNA (ctDNA) because this year July 2022, an ESMO guideline was published regarding the application of ctDNA in patient care. In the near future the data obtained...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776613/ https://www.ncbi.nlm.nih.gov/pubmed/36551600 http://dx.doi.org/10.3390/cancers14246115 |